Market Overview:
The global infection surveillance solutions market reached a value of US$ 514.1 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,158.50 Million by 2027, exhibiting at a CAGR of 13.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Infection surveillance solutions assist healthcare personnel in collecting, analyzing, and interpreting data about patients who are suffering from different infections. They notify hospital internet protocol and enable doctors as well as nurses in treating patients by providing dissemination of information. They also help diagnose antibiotic-resistant organisms (AROs), lower respiratory tract infections, and prevent ventilator-associated pneumonia, urinary tract, surgical wound and central line bloodstream. In addition, infection surveillance solutions identify epidemics and offer accurate employee health details, surgical database, real-time medical records, shifts in microbial pathogens.
Infection Surveillance Solutions Market Trends:
The growing prevalence of hospital-acquired infections (HAIs) on account of poor hygienic conditions and negligence by medical staff represents one of the major factors driving the market. Moreover, governments of numerous countries are undertaking initiatives to enhance the quality of care and safety of patients and prevent HAIs. This, along with the rising healthcare expenditure and high adoption rate of improved IT systems in hospitals to maintain electronic healthcare records (EHR), is propelling the growth of the market. In addition, the growing geriatric population and the increasing number of surgeries worldwide are positively influencing the market of infection surveillance solutions. Apart from this, healthcare information and technology (IT) companies are introducing innovative solutions in data management, analytics, and infrastructures that provide convenient data collection of infections and epidemics. This, in confluence with several developments in surveillance solutions to aid medical staff in understanding the software and its usage, is strengthening the market growth. Other factors projected to offer lucrative growth opportunities to key players operating in the market are the increasing adoption of cloud-based software and the escalating demand for web-based solutions and mobile platforms.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global infection surveillance solutions market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on component, deployment type and end user.
Breakup by Component:
Breakup by Deployment Type:
Breakup by End User:
- Hospitals
- Clinics
- Ambulatory Service Centers
- Specialty Centers
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Becton Dickinson and Company, Centrak Inc. (Halma plc), Cerner Corporation, CKM Healthcare Incorporated, Ecolab Inc., International Business Machines Corporation, Medexter Healthcare, Perahealth Inc., PointClickCare, Premier Inc. and Sunquest Information Systems Inc. (Roper Technologies Inc.).
Report Coverage:
Report Features |
Details |
---|
Base Year of the Analysis |
2021 |
Historical Period |
2016-2021 |
Forecast Period |
2022-2027 |
Units |
US$ Million |
Segment Coverage |
Component, Deployment Type, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Baxter International Inc., Becton Dickinson and Company, Centrak Inc. (Halma plc), Cerner Corporation, CKM Healthcare Incorporated, Ecolab Inc., International Business Machines Corporation, Medexter Healthcare, Perahealth Inc., PointClickCare, Premier Inc. and Sunquest Information Systems Inc. (Roper Technologies Inc.). |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Infection Surveillance Solutions Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Software
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Deployment Type
7.1 On-premises
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cloud-based
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Ambulatory Service Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Specialty Centers
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Baxter International Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Becton Dickinson and Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Centrak Inc. (Halma plc)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Cerner Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 CKM Healthcare Incorporated
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Ecolab Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 International Business Machines Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Medexter Healthcare
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Perahealth Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 PointClickCare
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Premier Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Sunquest Information Systems Inc. (Roper Technologies Inc.)
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 SWOT Analysis
List of Figures
Figure 1: Global: Infection Surveillance Solutions Market: Major Drivers and Challenges
Figure 2: Global: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Infection Surveillance Solutions Market: Breakup by Component (in %), 2021
Figure 5: Global: Infection Surveillance Solutions Market: Breakup by Deployment Type (in %), 2021
Figure 6: Global: Infection Surveillance Solutions Market: Breakup by End User (in %), 2021
Figure 7: Global: Infection Surveillance Solutions Market: Breakup by Region (in %), 2021
Figure 8: Global: Infection Surveillance Solutions (Software) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Infection Surveillance Solutions (Software) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Infection Surveillance Solutions (Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Infection Surveillance Solutions (Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Infection Surveillance Solutions (On-premises) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Infection Surveillance Solutions (On-premises) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Infection Surveillance Solutions (Cloud-based) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Infection Surveillance Solutions (Cloud-based) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Infection Surveillance Solutions (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Infection Surveillance Solutions (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Infection Surveillance Solutions (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Infection Surveillance Solutions (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Infection Surveillance Solutions (Specialty Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Infection Surveillance Solutions (Specialty Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Infection Surveillance Solutions (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Infection Surveillance Solutions (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: North America: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: North America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: United States: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: United States: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Canada: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Canada: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Asia-Pacific: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Asia-Pacific: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: China: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: China: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Japan: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Japan: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: India: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: India: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: South Korea: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: South Korea: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Australia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Australia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Indonesia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Indonesia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Europe: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Europe: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Germany: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Germany: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: France: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: France: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: United Kingdom: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: United Kingdom: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Italy: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Italy: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Spain: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Spain: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Russia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Russia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Latin America: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Latin America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Brazil: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Brazil: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Mexico: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Mexico: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Middle East and Africa: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Middle East and Africa: Infection Surveillance Solutions Market: Breakup by Country (in %), 2021
Figure 74: Middle East and Africa: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Global: Infection Surveillance Solutions Industry: SWOT Analysis
Figure 76: Global: Infection Surveillance Solutions Industry: Value Chain Analysis
Figure 77: Global: Infection Surveillance Solutions Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Infection Surveillance Solutions Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Infection Surveillance Solutions Market Forecast: Breakup by Component (in Million US$), 2022-2027
Table 3: Global: Infection Surveillance Solutions Market Forecast: Breakup by Deployment Type (in Million US$), 2022-2027
Table 4: Global: Infection Surveillance Solutions Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Infection Surveillance Solutions Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Infection Surveillance Solutions Market: Competitive Structure
Table 7: Global: Infection Surveillance Solutions Market: Key Players